The applications of artificial intelligence and nanotechnology have been
increasing in various sectors of society, particularly the pharmaceutical industry. The
amalgamation of these two domains is allowing for improved patient data acquisition
and the design of nanomaterials for precision cancer medicine. The crosstalk between
the tools and techniques utilized in AI could improve the design of nanomedicine by
improving material properties and the selection of drug combinations. To this end, this
review discusses nanotechnology coupled with AI and its possible applications in the
future of precision cancer medicine.